sE-cadherin serves as a diagnostic and predictive parameter in prostate cancer patients.

J Exp Clin Cancer Res · 2015 · PMC4490684 · PMID 25967040

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

difference was apparentno p-value reported

The reason no distinct difference was apparent between the CD44 serum level in healthy subjects and tumor patients may have been because CD44 variants such as CD44v5, CD44v6 and CD44v10, possibly involved in prostate cancer progression, were not individually evaluated [ 36 , 37 ].

also in 455 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.